Cover ImageSALE
市場調查報告書

血管支架的全球市場:2016∼2020年

Global Vascular Stents Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 361441
出版日期 內容資訊 英文 83 Pages
訂單完成後即時交付
價格
Back to Top
血管支架的全球市場:2016∼2020年 Global Vascular Stents Market 2017-2021
出版日期: 2017年09月04日 內容資訊: 英文 83 Pages
簡介

血管支架,是採用不鏽鋼和合金開發的網膜圓柱形線,用於預防接受血管新生手術的患者出現動脈閉塞。有助於避免反復進行血管再阻塞治療的血液循環重組術。全球血管支架市場,預計2016∼2020年,以年複合成長率7.38%擴大。

本報告提供全球血管支架市場現狀與2020年的預測,市場規模與銷售趨勢,彙整主要供應商的競爭環境與簡介。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 血管支架:概要

  • 背景

第6章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 血管支架的各產品市場區隔

  • 冠狀動脈支架
  • 末梢血管支架

第8章 全球冠狀動脈支架市場

第9章 全球末梢血管支架市場

第10章 血管支架的各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第11章 血管支架市場促進要素

  • 心血管疾病的發病率
  • 微創手術的需求
  • 血管支架的接受性

第12章 促進要素的影響

第13章 血管支架市場課題

  • 替代品的威脅
  • 血管支架術的併發症
  • 嚴格的相關法規
  • 激烈競爭

第14章 促進要素與課題的影響

第15章 血管支架市場趨勢

第16章 供應商環境

  • 競爭模式
  • 主要供應商
  • 其他值得注意的供應商

第17章 附錄

第18章 關於Technavio

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR14598

About Vascular Stents

Vascular stents are used to treat diseases such as coronary artery diseases (CADs) peripheral artery diseases (PADs), cardiovascular diseases (CVDs), and stroke. The global vascular stents market is driven by technologically advanced and minimally invasive products. The incidence of diseases associated with vascular stents has been increasing globally, where the blood supply gets obstructed due to the deposition of calcified plaque in coronary arteries that supply blood to the heart muscles or peripheral arteries, which supply blood to the head, arms, stomach, and legs.

Technavio's analysts forecast the global vascular stents market to grow at a CAGR of 7.22% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global vascular stents market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Vascular Stents Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott
  • Boston Scientific
  • Cardinal Health
  • Cook Medical
  • Medtronic

Other Prominent Vendors

  • B. Braun
  • Biosensors International
  • BIOTRONIK
  • Fortimedix Surgical
  • InspireMD
  • lepumedical
  • Meril Life Sciences
  • MicroPort Scientific
  • Neovasc
  • *SORIN GROUP
  • Terumo Medical
  • W. L. Gore & Associates

Market driver

  • Increasing burden of vascular diseases
  • For a full, detailed list, view our report

Market challenge

  • Stringent regulations for product approval*
  • For a full, detailed list, view our report

Market trend

  • Technological advances in stents
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Market overview
  • Coronary stents
  • Peripheral vascular stents

PART 07: Market segmentation by end-user

  • Market overview

PART 08: Geographical segmentation

  • Market scenario
  • Americas
  • EMEA
  • APAC

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Market challenges

PART 11: Market trends

  • Technological advances in stents*
  • Increase in M&A
  • Growing number of cath labs

PART 12: Vendor landscape

  • Competitive scenario
  • Other prominent vendors

PART 13: Key vendor analysis

  • Abbott
  • Boston Scientific
  • Cardinal Health
  • Cook Medical
  • Medtronic

PART 14: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Market scenario for vascular stents
  • Exhibit 02: Global vascular stents market overview by geography 2016
  • Exhibit 03: Global vascular stents market 2016-2021 ($ millions)
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Global vascular stents market segmentation by product 2016
  • Exhibit 06: Global vascular stents market segmentation by product 2021
  • Exhibit 07: Global coronary stents market 2016-2021 ($ millions)
  • Exhibit 08: BMS: Market overview
  • Exhibit 09: DES: Market overview
  • Exhibit 10: BRS: Market overview
  • Exhibit 11: Global peripheral vascular stents market 2016-2021 ($ millions)
  • Exhibit 12: Global vascular stents market overview by end-user segment
  • Exhibit 13: Global vascular stents market by geography 2016 (%)
  • Exhibit 14: Global vascular stents market by geography 2021 (%)
  • Exhibit 15: Vascular stents market in Americas 2016-2021 ($ millions)
  • Exhibit 16: Prevalence of vascular diseases in the US
  • Exhibit 17: Vascular stents market in EMEA 2016-2021 ($ millions)
  • Exhibit 18: Vascular stents market in APAC 2016-2021 ($ millions)
  • Exhibit 19: Prevalence of vascular diseases
  • Exhibit 20: Reimbursement for vascular stent procedures
  • Exhibit 21: Major transactions in the segment
  • Exhibit 22: Competitive structure analysis of global vascular stents market 2016
  • Exhibit 23: Abbott: Key highlights
  • Exhibit 24: Abbott: Strength assessment
  • Exhibit 25: Abbott: Strategy assessment
  • Exhibit 26: Abbott: Opportunity assessment
  • Exhibit 27: Boston Scientific: Key highlights
  • Exhibit 28: Boston Scientific: Strength assessment
  • Exhibit 29: Boston Scientific: Strategy assessment
  • Exhibit 30: Boston Scientific: Opportunity assessment
  • Exhibit 31: Cardinal Health: Key highlights
  • Exhibit 32: Cardinal Health: Strength assessment
  • Exhibit 33: Cardinal Health: Strategy assessment
  • Exhibit 34: Cardinal Health: Opportunity assessment
  • Exhibit 35: Cook Medical: Key highlights
  • Exhibit 36: Cook Medical: Strength assessment
  • Exhibit 37: Cook Medical: Strategy assessment
  • Exhibit 38: Cook Medical: Opportunity assessment
  • Exhibit 39: Medtronic: Revenue by product segment 2017 (%)
  • Exhibit 40: Medtronic: Key highlights
  • Exhibit 41: Medtronic: Strength assessment
  • Exhibit 42: Medtronic: Strategy assessment
  • Exhibit 43: Medtronic: Opportunity assessment
Back to Top